Has Diane Quintana received payments from drug or device companies?

Yes. Drug and device makers reported $7,862 in general payments to Diane Quintana across 367 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Diane Quintana did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Diane Quintana come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Diane Quintana

Psychiatric/Mental Health · El Paso, TXNPI 1104430982

Payments from drug & device makers

$7,862in general payments, 2019–2025

Across 367 payments — averaging $21.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Alkermes, Inc.$941
Axsome Therapeutics, Inc.$824
Otsuka America Pharmaceutical, Inc.$768
Johnson & Johnson$620
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$567
plus $2K from 10 others

What the payments were for

Speaking & faculty fees$6008%
Food & beverage$7,26292%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	75	$1,763
Alkermes, Inc.	69	$941
Axsome Therapeutics, Inc.	27	$824
Otsuka America Pharmaceutical, Inc.	39	$768
Johnson & Johnson	20	$620
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	25	$567
Corium, LLC	22	$452
E.r. Squibb & Sons, L.L.C.	17	$437
Supernus Pharmaceuticals, Inc.	10	$370
Teva Pharmaceuticals USA, Inc.	17	$335
Takeda Pharmaceuticals U.S.A., Inc.	11	$286
Neurocrine Biosciences, Inc.	10	$183
Lundbeck LLC	14	$149
Ironshore Pharmaceuticals Inc.	7	$109
Collegium Pharmaceutical, Inc.	3	$44
Sage Therapeutics, LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,862 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RexultiBrexpiprazole	55	$96,236
VraylarCariprazine Hcl	56	$80,936
SpravatoEsketamine Hcl	38	$44,517
Quetiapine Fumarate	104	$1,424
Doxepin Hcl	16	$1,326
Trazodone Hcl	115	$1,289
Buspirone Hcl	56	$1,062
Oxcarbazepine	16	$960
Hydroxyzine Pamoate	55	$695
Mirtazapine	48	$623
Duloxetine Hcl	34	$512
Prazosin Hcl	42	$494
Hydroxyzine Hcl	39	$482
Sertraline Hcl	110	$436
Risperidone	14	$405

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti	$768	$96,23655 claims
AbbVieVraylar	$1,763	$80,93656 claims
Johnson & JohnsonSpravato	$620	$44,51738 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in El Paso

Victor IlogEl Paso$167K
Alfredo ArellanoEl Paso$55K
Tracy HicksLongview$684K
Natalie TellezHouston$602K
Karah BrashierRichardson$567K
Grant DavisRichardson$360K
Lisa ShamblinGrapevine$163K
Monique GonzalezSan Antonio$126K
Marguerite AddisonWaco$118K
Komi Kokou-AbiRound Rock$88K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →